Ketorolac Tromethamine API Market

Ketorolac Tromethamine is the tromethamine salt of ketorolac, a synthetic pyrrolizine carboxylic acid derivative with anti-inflammatory, analgesic and antipyretic properties. Ketorolac tromethamine, a non-selective inhibitor of the cyclooxygenases (COX), inhibits both COX-1 and COX-2 enzymes. This agent exerts its anti-inflammatory effect by preventing conversion of arachidonic acid to prostaglandins at inflammation site mediated through inhibition of COX-2, which is undetectable in most tissues but is up-regulated at the inflammation sites. Since COX-1 is expressed virtually in all tissues, inhibition of COX-1 enzyme by this agent prevents normal state production of prostaglandins, which plays housekeeping roles in the protection of the gastrointestinal tract, regulating renal blood flow, and functioning in platelet aggregation. As a result, inhibition of COX-1 is usually associated with adverse effects such as gastrointestinal toxicity and nephrotoxicity. Ketorolac Tromethamine API Market aims to provide a comprehensive presentation of the global market for Ketorolac Tromethamine API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ketorolac Tromethamine API. Ketorolac Tromethamine API Market contains market size and forecasts of Ketorolac Tromethamine API in global, including the following market information: Global Ketorolac Tromethamine API Market Revenue, 2018-2023, 2024-2030, ($ millions) Global Ketorolac Tromethamine API Market Sales, 2018-2023, 2024-2030, (Kiloton) Global top five Ketorolac Tromethamine API companies in 2022 (%) The global Ketorolac Tromethamine API market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million. Purity?98% Segment to Reach $ Million by 2029, with a % CAGR in next six years. The global key manufacturers of Ketorolac Tromethamine API include Dr. Reddy?s Laboratories Ltd., Farmak A.S, UQUIFA, Symed Labs Limited, Vasudha Pharma Chem Limited, Recordati, Smilax Laboratories Limited, Nishchem International Pvt. Ltd. and Chromo Laboratories India Pvt Ltd, etc. in 2022, the global top five players have a share approximately % in terms of revenue. We surveyed the Ketorolac Tromethamine API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks. Total Market by Segment: Global Ketorolac Tromethamine API Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (Kiloton) Global Ketorolac Tromethamine API Market Segment Percentages, by Type, 2022 (%) Purity?98% Purity<98% Global Ketorolac Tromethamine API Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (Kiloton) Global Ketorolac Tromethamine API Market Segment Percentages, by Application, 2022 (%) Ketorolac Tromethamine Capsules Ketorolac Tromethamine Tablets Ketorolac Tromethamine Injection Others Global Ketorolac Tromethamine API Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (Kiloton) Global Ketorolac Tromethamine API Market Segment Percentages, By Region and Country, 2022 (%) North America US Canada Mexico Europe Germany France U.K. Italy Russia Nordic Countries Benelux Rest of Europe Asia China Japan South Korea Southeast Asia India Rest of Asia South America Brazil Argentina Rest of South America Middle East & Africa Turkey Israel Saudi Arabia UAE Rest of Middle East & Africa Competitor Analysis The report also provides analysis of leading market participants including: Key companies Ketorolac Tromethamine API revenues in global market, 2018-2023 (Estimated), ($ millions) Key companies Ketorolac Tromethamine API revenues share in global market, 2022 (%) Key companies Ketorolac Tromethamine API sales in global market, 2018-2023 (Estimated), (Kiloton) Key companies Ketorolac Tromethamine API sales share in global market, 2022 (%) Further, the report presents profiles of competitors in the market, key players include: Dr. Reddy?s Laboratories Ltd. Farmak A.S UQUIFA Symed Labs Limited Vasudha Pharma Chem Limited Recordati Smilax Laboratories Limited Nishchem International Pvt. Ltd. Chromo Laboratories India Pvt Ltd Renanpharma Zhejiang Charioteer Pharmaceutical Co.,Ltd Outline of Major Chapters: Chapter 1: Introduces the definition of Ketorolac Tromethamine API, market overview. Chapter 2: Global Ketorolac Tromethamine API market size in revenue and volume. Chapter 3: Detailed analysis of Ketorolac Tromethamine API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc. Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 6: Sales of Ketorolac Tromethamine API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world. Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. Chapter 8: Global Ketorolac Tromethamine API capacity by region & country. Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry. Chapter 11: The main points and conclusions of the report.